(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-24 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 2073602
Date | Daily Closing Price | Open | High | Low | Volume |
24 Tue Dec 2024 | 40.94 | 40.48 | 41.01 | 39.80 | 0.366 times |
23 Mon Dec 2024 | 40.48 | 40.82 | 40.83 | 39.77 | 0.73 times |
20 Fri Dec 2024 | 40.72 | 40.25 | 41.02 | 39.41 | 1.611 times |
19 Thu Dec 2024 | 40.38 | 41.68 | 41.76 | 39.80 | 1.119 times |
18 Wed Dec 2024 | 41.06 | 44.84 | 44.99 | 40.61 | 1.13 times |
17 Tue Dec 2024 | 44.63 | 44.12 | 44.92 | 43.40 | 0.651 times |
16 Mon Dec 2024 | 44.24 | 43.95 | 45.16 | 43.74 | 0.75 times |
13 Fri Dec 2024 | 43.78 | 45.01 | 45.34 | 42.86 | 1.529 times |
12 Thu Dec 2024 | 45.40 | 47.41 | 47.68 | 45.39 | 0.949 times |
11 Wed Dec 2024 | 47.78 | 49.00 | 49.38 | 47.41 | 0.724 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 42.3, but if it comes above 42.3, then a intra day buy could be more profitable.
If you take a sell trade below 42.3, then use 42.3 as stoploss and 38.3 as target. However if you take a buy trade in stock , then use 42.3 as stoploss and 45.63 as target.
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 39.41 |
Upside Target | 41.01 |
Upside Target | 42.86 |
Upside Target | 44.44 |
Upside Target | 48.49 |
Upside Target | 50.50 |
Upside Target | 50.63 |
Upside Target | 51.73 |
Upside Target | 51.99 |
Upside Target | 53.97 |
Upside Target | 57.68 |
Upside Target | 59.07 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 40.14 |
Downside Intraday Target | 39.33 |
Upside Intraday Target | 41.38 |
Upside Intraday Target | 41.81 |
Downside Intraday Target | 40.57 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
24 Tue Dec 2024 | 40.94 | 40.82 | 41.01 | 39.77 | 0.208 times |
20 Fri Dec 2024 | 40.72 | 43.95 | 45.16 | 39.41 | 1.052 times |
13 Fri Dec 2024 | 43.78 | 53.00 | 53.97 | 42.86 | 8.713 times |
26 Tue Nov 2024 | 49.31 | 50.00 | 50.63 | 48.49 | 0.349 times |
26 Tue Nov 2024 | 49.31 | 49.21 | 51.73 | 48.49 | 0.375 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
24 Tue Dec 2024 | 40.94 | 53.00 | 53.97 | 39.41 | 0.624 times |
26 Tue Nov 2024 | 49.31 | 46.96 | 59.07 | 45.51 | 1.534 times |
31 Thu Oct 2024 | 46.39 | 47.00 | 50.50 | 44.44 | 1.167 times |
30 Mon Sep 2024 | 46.98 | 47.37 | 51.99 | 43.42 | 0.769 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 42.74 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 42.74 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.